Name Change
Shareholders of MDS Inc. have approved a change of name from MDS Inc. to Nordion Inc. The company anticipates that the name change will be finalized in Q4 2010. As such, you will see references to both MDS Inc. and MDS Nordion on this website.
Board of Directors
William D. Anderson
Chair, Board of Directors
Member of the EHS & Governance Committee
William Anderson of Toronto, Canada, has served on the Board since February 2007, and became Chairman in February 2010. Mr. Anderson is a Chartered Accountant and a Corporate Director, having retired in 2005 after serving 14 years with BCE Inc. From 2001 to 2004, Mr. Anderson was President of BCE Ventures, and from 1997 to 2000, was Chief Financial Officer of BCE Inc. Mr. Anderson is also a director of TransAlta Corporation and Gildan Activewear Inc.
William G. Dempsey
Chair, Technology Committee
Member of the Finance & Audit Committee
Member of the EHS & Governance Committee
Bill Dempsey of Green Oaks, U.S., was appointed to the Board in 2008. Mr. Dempsey was an Executive with Abbott Laboratories for 25 years, prior to his retirement in 2007. His assignments included Executive Vice-President of the Pharmaceutical Products Group and Senior Vice-President of International Operations. Mr. Dempsey is a former Director of TAP Pharmaceutical Products Inc., and is currently a Director of TyRx, Inc., Landauer Inc. and the MPD Foundation.
William A. Etherington
Chair of the Human Resources & Compensation Committee
Member of the Finance & Audit Committee
Bill Etherington of Toronto, Canada, has served on the Board of the Company since 2001. Mr. Etherington is Chairman, Canadian Imperial Bank of Commerce. Prior to 2001, Mr. Etherington was Senior Vice-President & Group Executive, Sales & Distribution, IBM Corporation and Chairman, President and Chief Executive Officer, IBM World Trade Corporation. Mr. Etherington is also a Director of Celestica Inc., Onex Corporation, SS&C Technologies, Inc., and St. Michael's Hospital. He is also a member of the President’s Council, University of Western Ontario.
Robert W. Luba
Chair, Finance & Audit Committee
Member of the Human Resources & Compensation Committee
Bob Luba of Toronto, Canada, was appointed to the Board in 1996, and was named Chairman of the Audit Committee in February 2010. Mr. Luba is President, Luba Financial Inc. Prior to 1994, he was President and Chief Executive Officer of Royal Bank Investment Management Inc., President of Crown Life Insurance Company and Senior Vice-President of John Labatt Limited. Mr. Luba is also a Director of AIM Trimark Investments and Softchoice Corporation.
Mary A. Mogford
Chair of the EHS & Governance Committee
Member of the Human Resources & Compensation Committee
Mary Mogford of Newcastle, Canada, was appointed to the Board of the Company in 1998. She is a Corporate Director and a former Deputy Minister of Finance and Deputy Minister of Natural Resources for the Province of Ontario. Ms. Mogford is also a Director of the Potash Corporation of Saskatchewan and the SickKids Foundation Board. She was made a Fellow of the Institute of Corporate Directors in 2002 in recognition of her contribution to corporate governance in Canada. In 2004, Ms. Mogford was one of the first Directors accredited to the ICD/Rotman School of Management Directors Education Program.
Kenneth Newport
Ken Newport of Ottawa, Canada was appointed to the Board in 2010. A chartered accountant, entrepreneur and life sciences business executive, Mr. Newport served as Senior Vice President and Executive Committee member at PRA International Inc. for three years until his retirement in 2005. In the mid-nineties he was co-founder and President of CroMedica Inc., a clinical trials contract research organization which was sold to PRA International in 2002. Mr. Newport was also a founding member of Global Biomedical Capital Corporation, Zelos Therapeutics Inc., Prime Trials Inc. and other life science organizations. He is a member of the Institute of Corporate Directors and serves on the corporate Boards of The Opmedic Group, Jennerex Inc, and Medgenesis Therapeutics Inc.
Dr. Oye Olukotun
Member of the Human Resources & Compensation Committee
Member of the Technology Committee
Oye Olukotun of Princeton, U.S., has served on the Board of the Company since 2010. Dr. Olukotun is the Chief Executive Officer of CardioVax Inc. He is a co-founder of VIA Pharmaceuticals and served as the Chief Medical Officer since the company's formation. He is a Board Certified Cardiologist and has more than 25 years of experience in clinical research and drug development in the pharmaceutical industry with companies such as Esperion Therapeutics, Mallinckrodt, Inc. and Bristol-Myers Squibb Company. Dr. Olukotun is also a Director of Icagen, Inc., SemBioSys Genetics, Inc. and BioClinica Inc.
Steve M. West
Chief Executive Officer, MDS Inc.
President, MDS Nordion
Member of the Technology Committee
Steve West was appointed Chief Executive Officer of MDS Inc. in January 2010. Mr. West, who in September 2009 was appointed Chief Operating Officer of MDS Inc., has served as President of MDS Nordion since April 2003. He joined MDS Capital Corp. (now Lumira Capital) in 2001 as a senior partner after serving as President, DiverseyLever Canada. His background includes various CEO assignments in Asia and the Pacific Rim, as well as international business-development responsibilities in the specialty chemicals field.